Company Profile
NEUROPHET is a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases. The company offers Neurophet AQUA, AI-powered diagnosis assistant software for brain diseases.
Its portfolio also includes Neurophet SCALE PET, a software that quantitatively analyzes biomarkers targeted by a specific radiotracer using PET, Neurophet tES LAB, AI-Powered software to generate a 3D model using brain MRI and simulate electrical stimulation for treatment planning, and Neurophet innk, a non-invasive electrical stimulation device designed to aid in the functional recovery and rehabilitation of patients with brain diseases
Consulting services for design systems and quality management systems. The company has a strategic collaboration with VHIR Vall d'Hebron Institut de Recerca for the development of AI algorithms that detect multiple sclerosis lesions using MRI data. Founded in 2016, the company is headquartered in Seoul, South Korea.